Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

L-Glutamine and Reduced Oral Mucositis Severity

Research synthesisModerate evidenceSmall effect5 studies · 3 beneficial · 2 neutral · 0 harmful

Across 5 studies, 3 reported beneficial effects of L-glutamine on reducing oral mucositis severity, with effect sizes ranging from small to moderate; 2 studies found neutral effects. The evidence is drawn from clinical populations, primarily patients with cancer undergoing treatment, with a median study duration of 49 days. The most-studied dose was 5 g of L-glutamine (in one study), though dosing information was limited.

  • Studied populations: patients with cancer (including head and neck cancer and pediatric patients) receiving chemotherapy or radiotherapy

Caveats: Available evidence is overwhelmingly positive — clinical literature in this area is subject to publication bias (null-result studies are less likely to be published or indexed). Evidence base is small (only 5 studies) — conclusions should be considered preliminary. Dosing information was only available in one study, limiting generalizability.

Generated Jun 12, 2026
Doses used in studies
  • g/day: 5 (median 5, IQR 55) 1 study
Time to effect
Median: 7 weeks · IQR 7 weeks7 weeks · Range 7 weeks7 weeks — Reported in 1 of 5 studies
Safety in these studies
5 of 5 papers
Back to top